FindTrial
Sign In

The Role of ACSL4 in Promoting Prostate Cancer Metastasis through Lipid Metabolism and Ferroptosis: Toward Precision Targeted Therapy

The Role of ACSL4 in Promoting Prostate Cancer Metastasis through Lipid Metabolism and Ferroptosis: Toward Precision Targeted Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113163
Enrollment
Unknown
Registered
2025-11-25
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer metastasis

Interventions

Non-metastatic prostate cancer group:None
Metastatic prostate cancer group:None

Sponsors

Ningbo University Affiliated First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Diagnosed with primary prostate cancer, regardless of pathological type

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The level of ACSL4 mRNA in exosomes from plasma samples;The level of ACSL4 protein in exosomes from plasma samples;—

Countries

China

Contacts

Public ContactZhang Dongxu

Ningbo University Affiliated First Hospital

zdx570786324@126.com+86 574 8708 5588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026